Jonathan Lovell's profile

Jonathan Lovell

Cofounder

POP Biotechnologies

No background info available

Check back soon. More details may be added later.

Partnering listings

Learn more

POP Biotechnologies

Recombinant liposome-displayed H5 vaccine for HPAI poultry

POP Biotechnologies introduces a novel vaccine platform using SNAP technology to enhance immune responses against HPAI in poultry. The recombinant, liposome-displayed H5 vaccine aims to provide robust protection with dos...

TechnologyIn developmentCompany

Jonathan Lovell

Cofounder

POP Biotechnologies

Work experience

POP Biotechnologies

Cofounder

Top industry applications

Not enough data yet.
Results may appear later and can be imperfect.

Open to opportunities in

Not enough data yet.
Results may appear later and can be imperfect.

Last updated Oct 2025